Evidence map›Paper›PMID 32707226›Full record

Observational studyThe Journal of allergy and clinical immunology2021

Cardiovascular changes during peanut-induced allergic reactions in human subjects.

Monica Ruiz-Garcia, Joan Bartra, Olaya Alvarez, Ashna Lakhani, Shalinee Patel, Alistair Tang, Marcus Sim, Mohamed H Shamji, Isabel Skypala, E N Clare Mills and 5 more

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in The Journal of allergy and clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Detection of Anaphylaxis Through the Cutaneous Barrier.Current allergy and asthma reports · 2025
    Review
  6. Review
  7. Adrenaline Auto-Injectors for Preventing Fatal Anaphylaxis.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2025
    Review
  8. Anaphylaxis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2024
    Review
  9. Article
  10. Management of Refractory Anaphylaxis: An Overview of Current Guidelines.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2024
    Review
  11. Who Needs Epinephrine? Anaphylaxis, Autoinjectors, and Parachutes.The journal of allergy and clinical immunology. In practice · 2023
    Review
  12. Article
  13. Article
  14. International recommendations on epinephrine auto-injector doses often differ from standard weight-based guidance: a review and clinical proposals.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Review
  15. Emergency treatment of anaphylaxis: concise clinical guidance.Clinical medicine (London, England) · 2022
    Article
  16. Anaphylaxis knowledge gaps and future research priorities: A consensus report.The Journal of allergy and clinical immunology · 2022
    Article
  17. Article
  18. Review
  19. Review
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Monica Ruiz-GarciaSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Joan BartraSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Hospital Clínic Barcelona, Barcelona, Spain.
Olaya AlvarezSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Ashna LakhaniSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Shalinee PatelSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Alistair TangSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Marcus SimSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Mohamed H ShamjiSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Isabel SkypalaSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Royal Brompton and Harefield Hospitals NHS Foundation Trust, London, United Kingdom.
E N Clare MillsDivision of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, University of Manchester, Manchester, United Kingdom.
Alexander R LyonMyocardial Function, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Cardiology Department, Royal Brompton and Harefield Hospitals NHS Foundation Trust, London, United Kingdom.
Carl HaywardMyocardial Function, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Cardiology Department, Royal Brompton and Harefield Hospitals NHS Foundation Trust, London, United Kingdom; Barts Health NHS Trust, London, United Kingdom.
Stephen R DurhamSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom; Royal Brompton and Harefield Hospitals NHS Foundation Trust, London, United Kingdom.
Paul J TurnerSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom. Electronic address: p.turner@imperial.ac.uk.
Robert J BoyleSection of Inflammation, Repair and Development, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Imperial College London · GBUniversity of Manchester · GB

Funding

British Heart Foundation FS/11/67/28954Department of HealthMedical Research Council MR/K010468/1
6 · The paper itself

Abstract

backgroundFood allergy is the most common cause of anaphylaxis. Changes in posture during acute reactions can trigger fatal outcomes, but the impact of allergic reactions on the cardiovascular system in nonfatal reactions remains poorly understood.

objectiveOur aim was to systematically evaluate changes in cardiovascular function during acute allergic reactions to peanut.

methodsParticipants underwent double-blind placebo-controlled food challenge to peanut as part of a clinical trial. Changes in hemodynamic parameters (heart rate, stroke volume, blood pressure, and peripheral blood flow) and electrocardiogram findings during food challenges were assessed using noninvasive continuous monitoring.

resultsA total of 57 adults (median age 24 years [interquartile range = 20-29]), 53% of whom were female, participated; 22 (39%) had anaphylaxis. Acute reactions were associated with significant changes in stroke volume (mean decrease of 4.2% [95% CI = 0.8-7.6; P = .03]), heart rate (mean increase 11.6% [95% CI = 8.4-14.8; P < .0001]), and peripheral blood flow (mean increase 19.7% [95% CI = 10.8-28.6; P < .0001]), irrespective of reaction severity. These changes were reproduced at a subsequent repeat peanut challenge in 26 participants, and could be reversed with administration of intravenous fluids which resulted in faster resolution of abdominal symptoms.

conclusionsIn this first detailed human study of cardiovascular changes during food-induced allergic reactions, we found evidence for significant fluid redistribution, independent of reaction severity. This provides a sound rationale for optimizing venous return during significant allergic reactions to food. Finally, these data provide a new paradigm for understanding severity in anaphylaxis, in which poor outcomes may occur as a result of a failure in compensatory mechanisms.

Indexed as

AnaphylaxisCardiovascular SystemHemodynamicsPeanut HypersensitivityAdultDouble-Blind MethodFemaleHumansMaleRandomized Controlled Trials as TopicYoung AdultAnaphylaxiscardiac outputcardiovascularfood allergensintravenous fluidsmanagementstroke volumevenous return

Identifiers

PMID32707226
PMCPMC7858218
OpenAlexW3045103472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.